Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Total Current Liabilities (2020 - 2025)

Bio Essence has reported Total Current Liabilities over the past 6 years, most recently at $2.4 million for Q4 2025.

  • For Q4 2025, Total Current Liabilities fell 12.97% year-over-year to $2.4 million; the TTM value through Dec 2025 reached $2.4 million, down 12.97%, while the annual FY2025 figure was $2.4 million, 12.97% down from the prior year.
  • Total Current Liabilities for Q4 2025 was $2.4 million at Bio Essence, down from $3.2 million in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $3.8 million in Q1 2023 and troughed at $1.5 million in Q2 2023.
  • A 5-year average of $2.9 million and a median of $3.0 million in 2024 define the central range for Total Current Liabilities.
  • Biggest five-year swings in Total Current Liabilities: crashed 52.53% in 2023 and later skyrocketed 104.2% in 2024.
  • Year by year, Total Current Liabilities stood at $2.8 million in 2021, then increased by 29.1% to $3.6 million in 2022, then tumbled by 31.12% to $2.5 million in 2023, then grew by 14.37% to $2.8 million in 2024, then dropped by 12.97% to $2.4 million in 2025.
  • Business Quant data shows Total Current Liabilities for BIOE at $2.4 million in Q4 2025, $3.2 million in Q3 2025, and $3.1 million in Q2 2025.